Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: Another viewpoint

International Journal of Gynecological Pathology

Volumn 21, Issue 3, 2002, Pages 217-223

  Kamoi, Seiryu ^a   AlJuboury, Muna I ^a   Akin, Marie Rose ^a   Silverberg, Steven G ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Endocervix; Endometrium; Immunohistochemistry

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 20; CYTOKERATIN 4; EOSIN; ESTROGEN RECEPTOR; HEMATOXYLIN; MONOCLONAL ANTIBODY; PARAFFIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN;

ADENOCARCINOMA; ARTICLE; CELL DIFFERENTIATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SCORING SYSTEM;

EID: 0036085041     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200207000-00003     Document Type: Article

References (29)

1. The fruits of our labors: Distinguishing endometrial from endocervical adenocarcinoma
2. A panel of immunohistochemical stains including carcinoembryonic antigen, vimentin, and estrogen receptor aids in the distinction between primary endometrial and endocervical adenocarcinomas
3. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological specimens
4. Endocervical and endometrial adenocarcinoma: An immunoperoxidase and immunohistochemical study
5. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns
6. Selective applications of immunohistochemistry in gynecological neoplasms
7. The immunohistochemical discrimination of endometrioid adenocarcinomas
8. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium
9. Hormone receptor immunohistochemistry (IHC) and HPV in situ hybridization (ISH) are useful for distinguishing between primary endocervical and endometrial adenocarcinomas
10. Distinction between endometrial and endocervical adenocarcinoma: An immunohistochemical study
11. The distinction of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas
12. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix
13. Histogenetic interpretation of immunohistochemical staining results
14. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)
15. Histogenesis and differentiation: A reevaluation of these concepts as criteria for the classification of neoplasms
16. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma
17. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma
18. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites
19. Primary mucinous adenocarcinoma of the endometrium
20. Invasive adenocarcinoma and related tumors of the uterine cervix
21. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups
22. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: An immunohistochemical comparison of 34 cases
23. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms
24. CD10 is a marker for normal and neoplastic endometrial stromal cells
25. Carcinoma of the lower uterine segment: Clinicopathologic analysis of 12 cases
26. Tumors of the uterine isthmus: Clinicopathologic features and immunohistochemical characterization of p53 expression and hormone receptors
27. Clinicopathologic and immunohistochemical features and microsatellite status of endometrial cancer of the uterine isthmus